Your browser doesn't support javascript.
loading
Distinct iron architecture in SF3B1-mutant myelodysplastic syndrome patients is linked to an SLC25A37 splice variant with a retained intron.
Visconte, V; Avishai, N; Mahfouz, R; Tabarroki, A; Cowen, J; Sharghi-Moshtaghin, R; Hitomi, M; Rogers, H J; Hasrouni, E; Phillips, J; Sekeres, M A; Heuer, A H; Saunthararajah, Y; Barnard, J; Tiu, R V.
Afiliação
  • Visconte V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Avishai N; Department of Materials Science and Engineering, Swagelok Center for Surface Analysis of Materials, Case Western Reserve University, Cleveland, OH, USA.
  • Mahfouz R; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Tabarroki A; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Cowen J; Department of Materials Science and Engineering, Swagelok Center for Surface Analysis of Materials, Case Western Reserve University, Cleveland, OH, USA.
  • Sharghi-Moshtaghin R; Department of Materials Science and Engineering, Swagelok Center for Surface Analysis of Materials, Case Western Reserve University, Cleveland, OH, USA.
  • Hitomi M; Electron Microscopy Facility, Case Western Reserve University, Cleveland, OH, USA.
  • Rogers HJ; Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH, USA.
  • Hasrouni E; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Phillips J; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Sekeres MA; 1] Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA [2] Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Heuer AH; Department of Materials Science and Engineering, Swagelok Center for Surface Analysis of Materials, Case Western Reserve University, Cleveland, OH, USA.
  • Saunthararajah Y; 1] Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA [2] Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Barnard J; Department of Quantitative Health Sciences, Cleveland Clinic, OH, USA.
  • Tiu RV; 1] Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA [2] Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Leukemia ; 29(1): 188-95, 2015 Jan.
Article em En | MEDLINE | ID: mdl-24854990

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Síndromes Mielodisplásicas / Íntrons / Splicing de RNA / Ribonucleoproteína Nuclear Pequena U2 / Proteínas de Transporte de Cátions / Proteínas Mitocondriais / Ferro / Mutação Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Síndromes Mielodisplásicas / Íntrons / Splicing de RNA / Ribonucleoproteína Nuclear Pequena U2 / Proteínas de Transporte de Cátions / Proteínas Mitocondriais / Ferro / Mutação Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos